| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.14▼ | 1.14▼ | 1.14▼ | 1.15▼ | 1.15▼ |
| MA10 | 1.15▼ | 1.15▼ | 1.15▼ | 1.18▼ | 1.22▼ |
| MA20 | 1.18▼ | 1.18▼ | 1.18▼ | 1.15▼ | 1.26▼ |
| MA50 | 1.19▼ | 1.18▼ | 1.17▼ | 1.22▼ | 1.32▼ |
| MA100 | 1.15▼ | 1.15▼ | 1.19▼ | 1.26▼ | 2.44▼ |
| MA200 | 1.16▼ | 1.22▼ | 1.23▼ | 1.30▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.011▼ | -0.012▼ | -0.003▼ | -0.005▼ |
| RSI | 32.848▼ | 34.990▼ | 36.972▼ | 42.981▼ | 41.283▼ |
| STOCH | 17.516▼ | 17.516▼ | 15.327▼ | 37.836 | 37.880 |
| WILL %R | -92.308▼ | -92.308▼ | -92.857▼ | -73.684 | -59.095 |
| CCI | -150.746▼ | -150.746▼ | -136.773▼ | -170.101▼ | -113.557▼ |
|
Monday, August 10, 2026 01:00 AM
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer, today announced the ...
|
|
Thursday, November 13, 2025 05:30 AM
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ("Telo" or the "Company"), a leader in diagnostic and prognostic innovation through its ...
|
|
Wednesday, August 27, 2025 06:15 PM
Telomir Pharmaceuticals Inc. (NASDAQ:TELO) shares surged 35.14% in after-hours trading to $2.00 on Wednesday, following the company’s announcement of promising in vitro data for its lead drug ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/08/26 | 1.14 | 1.14 | 1.075 | 1.11 | 52,486 |
| 11/08/26 | 1.17 | 1.1811 | 1.13 | 1.13 | 27,494 |
| 10/08/26 | 1.16 | 1.19 | 1.15 | 1.17 | 36,818 |
| 07/08/26 | 1.17 | 1.17 | 1.16 | 1.16 | 11,346 |
| 06/08/26 | 1.19 | 1.205 | 1.155 | 1.17 | 18,142 |
| 05/08/26 | 1.15 | 1.1851 | 1.13 | 1.18 | 74,637 |
| 04/08/26 | 1.25 | 1.25 | 1.15 | 1.15 | 76,496 |
| 03/08/26 | 1.25 | 1.25 | 1.20 | 1.24 | 54,379 |
| 31/07/26 | 1.25 | 1.25 | 1.18 | 1.21 | 43,808 |
| 30/07/26 | 1.22 | 1.25 | 1.21 | 1.25 | 68,925 |
|
|
||||
|
|
||||
|
|